Sector portfolio · VC firm · United States

Catalio Capital Management's Biotech portfolio

Catalio Capital Management has backed 40 Biotech startups in rounds we track, $5.5B between them, shown by the stage each has reached. The best-funded is Freenome.

40startups backed
4stages
$5.5Braised between them
Stage not reportedbiggest stage

Catalio Capital Management's whole portfolioCatalio Capital Management's profile

Stage not reported

16

Series C and later

9

Series B

8

Series A

7

Segment by segment

Stage not reported

16 startups · $1.9B raised

  1. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  2. ArriVentArriVent develops pharmaceutical products to cure presently untreatable cancer.United States$325M
  3. COMPASS PathwaysCompass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.United Kingdom$200M
  4. Affini-T TherapeuticsAffini-T Therapeutics is a clinical-stage precision immunotherapy company based in Watertown, Massachusetts.United States$175M
  5. AtaiBeckleyAtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.Germany$150M
  6. Syndeio BiosciencesSyndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to rUnited States$90M
  7. Protara TherapeuticsProtara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.United States$75M
  8. Sherlock BiosciencesSherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.United States$66M

Series C and later

9 startups · $2.4B raised

  1. AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
  2. Recursion PharmaceuticalsRecursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.United States$339M
  3. EeGenesisUnited States$329M
  4. Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
  5. SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M
  6. Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.United States$238M
  7. Aviceda TherapeuticsAviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018.United States$208M
  8. Alentis TherapeuticsAlentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.Switzerland$194M

Series B

8 startups · $676M raised

  1. SepternaSepterna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.United States$150M
  2. GlycoEraGlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.Switzerland$130M
  3. Lassen TherapeuticsLassen Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California.United States$85M
  4. CTCelsius TherapeuticsCelsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.United States$83M
  5. NextPoint TherapeuticsNextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.United States$76M
  6. DNA ScriptDNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.France$62M
  7. EvvyEvvy is a women's health technology company based in New York, focused on addressing the gender health gap through precision medicine.United States$54M
  8. Spiral TherapeuticsSpiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.United States$36M

Series A

7 startups · $523M raised

  1. Clasp TherapeuticsClasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology.United States$150M
  2. OnCusp TherapeuticsOnCusp Therapeutics, Inc.United States$100M
  3. Faze MedicinesFaze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$81M
  4. Pheast TherapeuticsPheast Therapeutics is a clinical-stage immuno-oncology company based in Palo Alto, California, with operations in Redwood City.United States$76M
  5. Haystack OncologyHaystack Oncology enables precision oncology to optimize treatment strategies.United States$56M
  6. Volastra TherapeuticsVolastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.United States$30M
  7. AnagenexAnagenex is a pre-clinical biotechnology company based in Lexington, Massachusetts, founded in 2019.United States$30M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Catalio Capital Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioCatalio Capital Management's AI portfolio10 startups · $1.9BPortfolio mapCatalio Capital Management portfolio map70 startups · $11BCo-investorsWho invests with Catalio Capital Management55 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426B

Raising from investors like Catalio Capital Management?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps